https://clinicaltrials.gov/ct2/show/NCT01781390?term=Teva st m cell ami&rank=1
This link to FDA TEVA stem cells shows AMI Sponsored by MESO, collaborator Teva! It is on Teva site as a P2 one of only two surviving lines from the original Teva Cephalon deal. In contrast Teva is sponsor for CHF. Seems low interest/ priority but a great adjunct and poor cousin to CHF and unsupported by Teva. MSB seems to be good at new lines but not finishing the job! Lots of shots at goal as SI says but we need some goals scored. Am I being too critical or is SI locking up lines for the future.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $2.114B | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.64 | $5.790M | 3.482M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 460 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 67181 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |